Company research / IRD
Opus Genetics, Inc. (IRD)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Opus Genetics, Inc. reported revenue of $14.20M. Revenue grew 29.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $9.86M.
Key ratios (year ended 2025-12-31)
-271.9%
Operating margin
-349.3%
Net margin
-323.1%
Return on year-end equity
29.1%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.